Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Simultaneous Effect of Valproic Acid and Gamma Radiation on Telomerase Activity and Bax and Bcl-2 Protein Levels in MCF-7 Breast Cancer Cell Line

Maryam Moradi Binabaj 1 , Seyed Ahmad Hosseini 2 , Alireza Khoshbin Khoshnazar 1 and Jahanbakhsh Asadi 1 , *
Authors Information
1 Biochemistry and Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, IR Iran
2 Nutrition and Metabolic Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 01, 2015, 10 (3); e22818
  • Published Online: August 28, 2015
  • Article Type: Research Article
  • Received: September 19, 2014
  • Revised: February 1, 2015
  • Accepted: April 15, 2015
  • DOI: 10.17795/jjnpp-22818

To Cite: Moradi Binabaj M, Hosseini S A, Khoshbin Khoshnazar A, Asadi J. The Simultaneous Effect of Valproic Acid and Gamma Radiation on Telomerase Activity and Bax and Bcl-2 Protein Levels in MCF-7 Breast Cancer Cell Line, Jundishapur J Nat Pharm Prod. 2015 ; 10(3):e22818. doi: 10.17795/jjnpp-22818.

Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet. 2012; 44(3): 312-8[DOI][PubMed]
  • 2. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000; 100(1): 57-70[DOI]
  • 3. Dive C, Hickman JA. Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer. 1991; 64(1): 192-6[PubMed]
  • 4. O'Connor PM, Wassermann K, Sarang M, Magrath I, Bohr VA, Kohn KW. Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res. 1991; 51(24): 6550-7[PubMed]
  • 5. Lowe SW, Ruley H, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993; 74(6): 957-67[DOI]
  • 6. Findley HW, Gu L, Yeager AM, Zhou M. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood. 1997; 89(8): 2986-93[PubMed]
  • 7. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 1993; 81(11): 3091-6[PubMed]
  • 8. Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia. 1995; 9(7): 1191-8[PubMed]
  • 9. MacNamara BARBARA, Wang W, Chen Z, Hou M, Mazur J, Gruber A, et al. Telomerase activity in relation to pro-and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas. haematologica. 2001; 86(4): 386-93
  • 10. Travaglini L, Vian L, Billi M, Grignani F, Nervi C. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status. Int J Biochem Cell Biol. 2009; 41(1): 225-34[DOI][PubMed]
  • 11. Schulpis KH, Lazaropoulou C, Regoutas S, Karikas GA, Margeli A, Tsakiris S, et al. Valproic acid monotherapy induces DNA oxidative damage. Toxicology. 2006; 217(2-3): 228-32[DOI][PubMed]
  • 12. Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer. 2004; 110(2): 301-8[DOI][PubMed]
  • 13. Chung YL, Wang AJ, Yao LF. Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Mol Cancer Ther. 2004; 3(3): 317-25[PubMed]
  • 14. Saha D, Maity T, Jana M, Mandal S. Cancer treatment strategy: an overview. Asian J Pharm Tech. 2011; 1: 28-33
  • 15. Ram R, Uziel O, Eldan O, Fenig E, Beery E, Lichtenberg S, et al. Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway. Clin Cancer Res. 2009; 15(3): 914-23[DOI][PubMed]
  • 16. Gupta R, Dong Y, Solomon PD, Wettersten HI, Cheng CJ, Min JN, et al. Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A. Proc Natl Acad Sci U S A. 2014; 111(30)-71[DOI][PubMed]
  • 17. Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol. 2011; 21(6): 349-53[DOI][PubMed]
  • 18. Philippi C, Loretz B, Schaefer UF, Lehr CM. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine. J Control Release. 2010; 146(2): 228-40[DOI][PubMed]
  • 19. Nie D, Huang K, Yin S, Li Y, Xie S, Ma L, et al. Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells. Leuk Lymphoma. 2012; 53(12): 2487-95[DOI][PubMed]
  • 20. Schuck A, Poremba C, Lanvers C, Konemann S, Schleifer T, Wai D, et al. Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor. Strahlenther Onkol. 2002; 178(12): 701-8[DOI][PubMed]
  • 21. Turriziani M, Di Giacomo AM, Cardillo A, Torino F, Tentori L, Nasuti P, et al. Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro. Anticancer Res. 2002; 23(6C): 4561-9
  • 22. Xing J, Zhu Y, Zhao H, Yang H, Chen M, Spitz MR, et al. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007; 16(3): 606-9[DOI][PubMed]
  • 23. Suenaga M, Soda H, Oka M, Yamaguchi A, Nakatomi K, Shiozawa K, et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mrna expression in prostate cancer cells. Int J Cancer. 2002; 97(5): 621-5[DOI]
  • 24. Khaw AK, Silasudjana M, Banerjee B, Suzuki M, Baskar R, Hande MP. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. Mutat Res. 2007; 625(1-2): 134-44[DOI][PubMed]
  • 25. Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, et al. Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res. 2001; 29(14): 3006-11[PubMed]
  • 26. Rahman R, Osteso-Ibanez T, Hirst RA, Levesley J, Kilday JP, Quinn S, et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. Mol Cancer Ther. 2010; 9(9): 2568-81[DOI][PubMed]
  • 27. Sawant SG, Antonacci ROBERTO, Pandita T. Determination of telomerase activity in HeLa cells after treatment with ionizing radiation by telomerase PCR ELISA. Biochemica. 1997; 4: 22-4
  • 28. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003; 22(53): 8590-607[DOI][PubMed]
  • 29. Park DI, Lee JH, Moon SK, Kim CH, Lee YT, Cheong J, et al. Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells. Pharmacol Res. 2005; 51(5): 437-43[DOI][PubMed]
  • 30. Woo HJ, Lee SJ, Choi BT, Park YM, Choi YH. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp Mol Pathol. 2007; 82(1): 77-84[DOI][PubMed]
  • 31. Karagiannis TC, El-Osta A. The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation. Cell Cycle. 2006; 5(3): 288-95[PubMed]
  • 32. Chen X, Wong P, Radany E, Wong JY. HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells. Cancer Biother Radiopharm. 2009; 24(6): 689-99[DOI][PubMed]
  • 33. Ramı́rez R, Carracedo J, Jiménez R, Canela A, Herrera E, Aljama P, et al. Massive telomere loss is an early event of DNA damage-induced apoptosis. J Biol Chem. 2003; 278(2): 836-42
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments